Page last updated: 2024-08-21

pyrimidine and decitabine

pyrimidine has been researched along with decitabine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Amoreo, CA; Bristow, CA; Buglioni, S; Cardone, L; Carrella, D; Carugo, A; Ciliberto, G; Del Bufalo, D; Di Bernardo, D; Draetta, GF; Fleming, JB; Huang, JK; Iezzi, M; Iuliano, A; Kang, Y; Kim, MP; Lamolinara, A; Manni, I; Melisi, D; Minelli, R; Mottini, C; Robinson, FS; Tomihara, H; Trisciuoglio, D1
Carraway, H; Durkin, L; Grabowski, D; Gu, X; Hamilton, B; Hasipek, M; Hong, C; Hsi, ED; Jha, BK; Maciejewski, J; Patel, B; Radivoyevitch, T; Sakre, N; Saunthararajah, Y; Schuerger, C; Sobecks, R; Tohme, R; Tomlinson, B; Zidan, AM1
Fukuda-Kurahashi, Y; Kamachi, K; Kimura, S; Kurahashi, Y; Ureshino, H; Watanabe, T; Yamamoto, Y; Yoshida-Sakai, N1

Other Studies

3 other study(ies) available for pyrimidine and decitabine

ArticleYear
Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocarcinoma.
    Cancer research, 2019, Nov-01, Volume: 79, Issue:21

    Topics: Adenocarcinoma; Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Decitabine; Drug Repositioning; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Mutation; Pancreatic Neoplasms; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Pyrimidines; Signal Transduction

2019
Decitabine- and 5-azacytidine resistance emerges from adaptive responses of the pyrimidine metabolism network.
    Leukemia, 2021, Volume: 35, Issue:4

    Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Decitabine; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA Methylation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Humans; Metabolic Networks and Pathways; Mice; Pyrimidines; Uridine Kinase

2021
Adult T-cell leukemia-lymphoma acquires resistance to DNA demethylating agents through dysregulation of enzymes involved in pyrimidine metabolism.
    International journal of cancer, 2022, 04-01, Volume: 150, Issue:7

    Topics: Antineoplastic Agents; Azacitidine; Cell Line, Tumor; Decitabine; Deoxycytidine Kinase; DNA Methylation; Drug Resistance, Neoplasm; Humans; Leukemia-Lymphoma, Adult T-Cell; Pyridines; Pyrimidines; Uridine Kinase

2022